Etoposide — Dosing in CKD & Dialysis

Etoposide (Antineoplastic): renal dosing adjustments, dialyzability (Not removed by hemodialysis (Yasuda 2021 review, PMID 33938097); the label gives no dialysis statement.), and renal-relevant safety risk for CKD and dialysis patients. Educational reference for nephrology professionals.

Reviewed by Matt · November 16, 2026

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.